Rapport Therapeutics (RAPP) Revenue & Revenue Breakdown
Rapport Therapeutics Revenue Highlights
00
Rapport Therapeutics Revenue by Period
Rapport Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | - |
Rapport Therapeutics generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Rapport Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | - | -100.00% |
| 2026-03-31 | $20.00M | 100.00% |
| 2025-12-31 | - | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | - |
Rapport Therapeutics generated - in revenue during Q2 2026, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Rapport Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ACAD | Acadia Pharmaceuticals | $957.80M | $307.96M |
| AXSM | Axsome Therapeutics | $638.50M | $218.38M |
| RAPP | Rapport Therapeutics | - | - |
| CGTX | Cognition Therapeutics | - | - |
| CTNM | Contineum Therapeutics | - | - |
| NMRA | Neumora Therapeutics | - | - |
| MPLT | MapLight Therapeutics | - | - |
| ANRO | Alto Neuroscience | - | - |
| PRAX | Praxis Precision Medicines | - | - |
| LBRX | LB Pharmaceuticals | - | - |
| SPTX | Seaport Therapeutics | - | - |